[Current status of immunosuppressive therapy in non-neoplastic disorders].
D001168:Arthritis / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects; D001855:Bone Marrow Diseases / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007239:Infections / Q000209:etiology; D007674:Kidney Diseases / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D011379:Prognosis; D012871:Skin Diseases / Q000188:drug therapy
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate
Heutiger Stnd der immunsuppressiven Therapie bei nicht-neoplastischen Affektionen.